0001179110-12-007021.txt : 20120420 0001179110-12-007021.hdr.sgml : 20120420 20120420163047 ACCESSION NUMBER: 0001179110-12-007021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120420 FILED AS OF DATE: 20120420 DATE AS OF CHANGE: 20120420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HRUSOVSKY E KEVIN CENTRAL INDEX KEY: 0001252546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34105 FILM NUMBER: 12771135 MAIL ADDRESS: STREET 1: 68 ELM STREET CITY: HOPKINTON STATE: MA ZIP: 01748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SERACARE LIFE SCIENCES INC CENTRAL INDEX KEY: 0001156295 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330056054 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 37 BIRCH STREET CITY: MILFORD STATE: MA ZIP: 01757 BUSINESS PHONE: 5082446400 MAIL ADDRESS: STREET 1: 37 BIRCH STREET CITY: MILFORD STATE: MA ZIP: 01757 4 1 edgar.xml FORM 4 - X0305 4 2012-04-20 0 0001156295 SERACARE LIFE SCIENCES INC SRLS 0001252546 HRUSOVSKY E KEVIN C/O SERACARE LIFE SCIENCES, INC. 37 BIRCH STREET MILFORD MA 01757 1 0 0 0 Common Stock 2012-04-20 4 D 0 2739 D 0 D Stock Option (Right to Buy) 2.73 2012-04-20 4 D 0 3750 D 2016-11-16 Common Stock 3750 0 D Stock Option (Right to Buy) 2.73 2012-04-20 4 D 0 11250 D 2016-11-16 Common Stock 11250 0 D Stock Option (Right to Buy) 3.86 2012-04-20 4 D 0 7890 D 2015-11-17 Common Stock 7890 0 D Pursuant to the Agreement and Plan of Merger dated as of February 12, 2012, as amended by Amendment No. 1 to Agreement and Plan of Merger dated as of February 27, 2012, among SeraCare Life Sciences, Inc., Project Plasma Holdings Corporation and Project Plasma Merger Corp. (the "Merger Agreement"), each share of SeraCare Life Sciences, Inc.'s common stock was exchanged for $4.00 in cash, without interest and less any applicable withholding taxes. Pursuant to its terms, the stock option accelerated and became fully vested as of the closing of the merger. This stock option is fully vested. Pursuant to the Merger Agreement, each stock option was cancelled in the merger in exchange for the right to receive an amount in cash, without interest, equal to the product of the number of shares issuable upon the exercise of such stock option and $4.00 minus the exercise price of such stock option, less any applicable withholding taxes. /s/ Gregory A. Gould, Attorney-in-fact 2012-04-20